BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21841772)

  • 1. H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency.
    Svotelis A; Bianco S; Madore J; Huppé G; Nordell-Markovits A; Mes-Masson AM; Gévry N
    EMBO J; 2011 Aug; 30(19):3947-61. PubMed ID: 21841772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
    Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
    BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone demethylase Jmjd3 regulates osteoblast apoptosis through targeting anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bim.
    Yang D; Okamura H; Teramachi J; Haneji T
    Biochim Biophys Acta; 2016 Apr; 1863(4):650-9. PubMed ID: 26795455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JMJD3 as an epigenetic regulator in development and disease.
    Burchfield JS; Li Q; Wang HY; Wang RF
    Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
    Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
    [No Abstract]   [Full Text] [Related]  

  • 8. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.
    Gao WW; Xiao RQ; Zhang WJ; Hu YR; Peng BL; Li WJ; He YH; Shen HF; Ding JC; Huang QX; Ye TY; Li Y; Liu ZY; Ding R; Rosenfeld MG; Liu W
    Mol Cell; 2018 Apr; 70(2):340-357.e8. PubMed ID: 29628309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.
    Shi L; Sun L; Li Q; Liang J; Yu W; Yi X; Yang X; Li Y; Han X; Zhang Y; Xuan C; Yao Z; Shang Y
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7541-6. PubMed ID: 21502505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.
    Si X; Zang R; Zhang E; Liu Y; Shi X; Zhang E; Shao L; Li A; Yang N; Han X; Pan B; Zhang Z; Sun L; Sun Y
    Oncotarget; 2016 Dec; 7(49):81452-81462. PubMed ID: 27845892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
    Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
    Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.
    Wu Y; Zhang Z; Cenciarini ME; Proietti CJ; Amasino M; Hong T; Yang M; Liao Y; Chiang HC; Kaklamani VG; Jeselsohn R; Vadlamudi RK; Huang TH; Li R; De Angelis C; Fu X; Elizalde PV; Schiff R; Brown M; Xu K
    Cancer Res; 2018 Feb; 78(3):671-684. PubMed ID: 29212856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
    J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JMJD6 regulates ERα methylation on arginine.
    Poulard C; Rambaud J; Hussein N; Corbo L; Le Romancer M
    PLoS One; 2014; 9(2):e87982. PubMed ID: 24498420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
    Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
    Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role and prospect of JMJD3 in stem cells and cancer.
    Yin X; Yang S; Zhang M; Yue Y
    Biomed Pharmacother; 2019 Oct; 118():109384. PubMed ID: 31545292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of a chromatin modifier on ischemia/reperfusion neurons: implication of its regulation of BCL2 transactivation by ERα signaling.
    Guo J; Zhang T; Yu J; Li HZ; Zhao C; Qiu J; Zhao B; Zhao J; Li W; Zhao TZ
    Cell Tissue Res; 2016 Jun; 364(3):475-488. PubMed ID: 26728277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HOTAIR promotes metastasis of renal cell carcinoma by up-regulating histone H3K27 demethylase JMJD3.
    Xia M; Yao L; Zhang Q; Wang F; Mei H; Guo X; Huang W
    Oncotarget; 2017 Mar; 8(12):19795-19802. PubMed ID: 28177890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells.
    Nassa G; Salvati A; Tarallo R; Gigantino V; Alexandrova E; Memoli D; Sellitto A; Rizzo F; Malanga D; Mirante T; Morelli E; Nees M; Åkerfelt M; Kangaspeska S; Nyman TA; Milanesi L; Giurato G; Weisz A
    Sci Adv; 2019 Feb; 5(2):eaav5590. PubMed ID: 30775443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.